Justin W. Yorke, Director at Processa Pharmaceuticals, Inc. (PCSA), sold 22,700 shares at $9.86 ($220K) on 2021-04-13, disclosed to the SEC on 2021-04-15.
Open-market sale of $220k PCSA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.86 | 6,500 | $64K | 29.2% |
| 2 | $9.86 | 6,500 | $64K | 29.2% |
| 3 | $9.42 | 9,700 | $91K | 41.6% |
| Total | $9.67 avg | 22,700 | $220K | 100% |
| Filing → |
| PCSA | SELL | 2022-01-31 | $6K | — | Filing → |
| PCSA | SELL | 2021-12-07 | $46K | — | Filing → |